← All organizations

Xalud Therapeutics, Inc.

For profitWebsite ↗

Also known as: Xalud Therapeutics | Xalud Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 28, 2025

Timeline

2000s

Jun 1, 2009
Xalud Therapeutics, Inc.— Founded

Drugs by trial phase (1 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

xt-150

Indications

Studied for

Recent trials (12)

NCT06704347Lead sponsorPhase 1Feb 28, 2025
NCT05196919Study directorPhase 2Feb 24, 2022
NCT05196919Lead sponsorPhase 2Feb 24, 2022
NCT04841512Lead sponsorPhase 1/Phase 2Jan 31, 2022
NCT04466410Lead sponsorPhase 1Oct 15, 2020
NCT04466410Study directorPhase 1Oct 15, 2020
NCT04124042Study chairPhase 2/Phase 3Jan 1, 2020
NCT04124042Lead sponsorPhase 2/Phase 3Jan 1, 2020
NCT03769662Lead sponsorPhase 1Mar 20, 2019
NCT03477487Study directorPhase 1Jun 8, 2018
NCT03477487Lead sponsorPhase 1Jun 8, 2018
NCT03282149Lead sponsorPhase 1Mar 21, 2018

Details

Founded: San Francisco, CA, US Jun 1, 2009
Last known activity: Feb 28, 2025